Full text loading...
On the applicability of the AAPM TG-60/TG-43 dose calculation formalism to intravascular line sources: Proposal for an adapted formalism
1.D. Liermann, J. Kirchner, R. Bauernsachs, B. Schopohl, and H. D. Böttcher, “Brachytherapy with iridium-192 HDR to prevent from restenosis in peripheral arteries: An update,” Herz 23, 394–400 (1998).
2.R. Waksman, J. R. Laird, A. J. Lansky, A. Brahimi, L. R. White, C. T. Jurkovitz, A. S. Kosinski, N. Murrah, and W. S. Weintraub, “One year follow-up after intravascular radiation therapy following balloon angioplasty of narrowed femoral-popliteal arteries: Results of the PARIS feasibility clinical trial,” J. Am. Coll. Cardiol. 35, 51 (2000).
3.M. A. Costa, M. Sabaté, P. Serrano, W. J. van der Giessen, K. Kozuma, I. P. Kay, V. L. M. A. Coen, J. M. R. Ligthart, A. Wardeh, P. C. Levendag, and P. W. Serruys, “The effect of beta-radiotherapy on both vessel remodeling and neointimal hyperplasia after coronary balloon angioplasty and stenting; A three-dimensional intravascular ultrasound investigation,” J. Invasive Cardiol. 12, 113–120 (2000).
4.A. E. Raizner, S. N. Oesterle, R. Waksman, P. W. Serruys, A. Colombo, Y. L. Lim, A. C. Yeung, W. J. van der Giessen, L. Vandertie, J. K. Chiu, L. R. White, P. J. Fitzgerald, G. L. Kaluza, and N. M. Ali, “Inhibition of restenosis with β-emitting radiotherapy, Report of the Proliferation Reduction With Vascular Energy Trial (PREVENT),” Circulation 102, 951–958 (2000).
5.S. B. King, III, D. O. Williams, P. Chougule, J. L. Klein, R. Waksman, R. Hilstead, J. Macdonald, K. Anderberg, and I. R. Crocker, “Endovascular β-radiation to reduce restenosis after coronary balloon angioplasty: Results of the beta energy restenosis trial (BERT),” Circulation 97, 2025–2030 (1998).
6.D. Meerkin, J. C. Tardif, I. R. Crocker, A. Arsenault, M. Joyal, G. Lucier, S. B. King, III, D. O. Williams, P. W. Serruys, and R. Bonan, “Effects of intracoronary β-radiation therapy after coronary angioplasty: An intravascular ultrasound study,” Circulation 99, 1660–1665 (1999).
7.R. Waksman, B. Bhargava, L. White, R. C. Chan, R. Mehran, A. J. Lansky, G. S. Mintz, L. F. Satler, A. D. Pichard, M. B. Leon, and K. K. Kent, “Intracoronary β-radiation therapy inhibits recurrence of in-stent restenosis,” Circulation 101, 1895–1898 (2000).
8.R. Waksman, “Progress in clinical trials for coronary arterial restenosis using beta radiation sources,” Cardiovasc. Radiat. Med. 1, 220–226 (1999).
9.P. S. Teirstein, V. Massullo, S. Jani, J. J. Popma, G. S. Mintz, R. J. Russo, R. A. Schatz, E. M. Guarneri, S. Steuterman, N. B. Morris, M. B. Leon, and P. Tripuraneni, “Catheter-based radiotherapy to inhibit restenosis after coronary stenting,” N. Engl. J. Med. 336, 1697–1703 (1997).
10.P. S. Teirstein, V. Massullo, S. Jani, J. J. Popma, R. J. Russo, R. A. Schatz, E. M. Guarneri, S. Steuterman, K. Sirkin, D. A. Cloutier, M. B. Leon, and P. Tripuraneni, “Three-year clinical and angiographic follow-up after intracoronary radiation: Results of a randomized clinical trial,” Circulation 101, 360–365 (2000).
11.J. A. Condado, R. Waksman, O. Gurdiel, R. Espinosa, J. Gonzalez, B. Burger, G. Villoria, H. Acquatella, I. R. Crocker, K. B. Seung, and S. F. Liprie, “Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans,” Circulation 96, 727–732 (1997).
12.R. Waksman, R. L. White, R. C. Chan, B. G. Bass, L. Geirlach, G. S. Mintz, L. F. Satler, R. Mehran, P. W. Serruys, A. J. Lansky, P. Fitzgerald, B. Bhargava, K. M. Kent, A. D. Pichard, and M. B. Leon, “Intracoronary γ-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis,” Circulation 101, 2165–2171 (2000).
13.R. Nath, H. Amols, C. Coffey, D. Duggan, S. Jani, Z. Li, M. Schell, C. Soares, J. Whiting, P. E. Cole, I. Crocker, and R. Schwartz, “Intravascular brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 60,” Med. Phys. 26, 119–152 (1999).
14.O. F. Bertrand, R. Mongrain, S. Lehnert, L. Bilodeau, J.-F. Tanguay, J. Laurier, G. Côté and M. G. Bourassa, “Intravascular radiation therapy in atherosclerotic disease: promises and premises,” Eur. Heart J. 18, 1385–1395 (1997).
15.D. A. Diamond and T. M. Vesely, “The role of radiation therapy in the management of vascular restenosis. Part I: Biological basis,” J. Vasc. Intervent. Radiol. 9, 199–208 (1998).
16.D. A. Diamond and T. M. Vesely, “The role of radiation therapy in the management of vascular restenosis. Part II: Radiation techniques and results,” J. Vasc. Intervent. Radiol. 9, 389–400 (1998).
17.J. Weinberger and A. D. Simon, “Intracoronary irradiation for the prevention of restenosis,” Current Opinion Cardiol. 12, 468–474 (1997).
18.D. Baumgart, U. Quast, and R. Erbel, “Die intravasale strahlenbehandlung zur kombinierten therapie und prävention der restenosierung,” Hertz 22, 335–3346 (1997) (in German).
19.R. Waksman, in Vascular Brachytherapy, 2nd ed. (Futura Publishing, Armonk, NY, 1999).
20.R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, “Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Task Group No. 43,” Med. Phys. 22, 209–234 (1995).
21.D. R. Schaart, A. J. J. Bos, A. J. M. Winkelman, and M. C. Clarijs, “Radial depth dose distribution of a W-188/Re-188 beta particle line source measured with ultra-thin TLD’s in a PMMA phantom,” to be published.
22.M. C. Clarijs, A. J. J. Bos, and D. R. Schaart, “Modelling of a W-188/Re-188 beta line source for coronary brachytherapy by means of EGS4 Monte Carlo simulations,” Phys. Med. Biol. 25, 1319–1334 (2000).
23.U. O. Häfeli, W. K. Roberts, D. S. Meier, J. P. Ciezki, G. J. Pauer, E. J. Lee, and M. S. Weinhous, “Dosimetry of a W-188/Re-188 beta line source for endovascular brachytherapy,” Med. Phys. 27, 668–675 (2000).
24.S. G. Carlier, J. P. A. Marijnissen, V. L. M. A. Coen, M. Sabaté, W. J. van der Giessen, J. Ligthart, A. den Boer, P. C. Levendag, and P. W. Serruys, “Comparison of brachytherapy strategies based on dose–volume histograms derived from quantitative intravascular ultrasound,” Cardiovasc. Radiat. Med. 2, 115–124 (1999).
25.M. Sabaté, J. P. A. Marijnissen, S. G. Carlier, I. P. Kay, W. J. van der Giessen, V. L. M. A. Coen, J. M. R. Ligthart, E. Boersma, M. A. Costa, P. C. Levendag, and P. W. Serruys, “Residual plaque burden, delivered dose, and tissue composition predict 6-month outcome after balloon angioplasty and β-radiation therapy,” Circulation 101, 1087–1090 (2000).
26.V. Verin and Y. Popowski, “Intraarterial beta irradiation to reduce restenosis after PTCA, experimental and clinical experience,” Herz 23, 335–346 (1998).
27.Data taken from the x-ray attenuation and absorption for materials of dosimetric interest (XAAMDI) database at the Physical Reference Data Web pages from the National Institute of Standards and Technology (NIST), http://physics.nist.gov/PhysRefData/contents.html, 1999.
28.W. G. Cross, “Empirical expressions for beta ray point source dose distributions,” Radiat. Prot. Dosim. 69, 85–96 (1997).
29.International Commission on Radiation Units and Measurements, ICRU Report 37, Stopping Powers for Electrons and Positrons (International Commission on Radiation Units and Measurements, Bethesda, MD, 1984).
30.W. J. F. Dries, “Integrating radiation therapy into the cath lab: safety and good practice,” Vascular Brachytherapy, State of the Art, edited by R. Bonan and R. Waksman (Remeda, London, UK, 1998).
31.M. Sabaté, M. A. Costa, K. Kozuma, I. P. Kay, W. J. van der Giessen, V. L. M. A. Coen, J. M. R. Ligthart, P. Serrano, P. C. Levendag, and P. W. Serruys, “Geographic miss, a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy,” Circulation 101, 2467–2471 (2000).
32.A. J. Lansky, J. J. Popma, V. Massullo, S. Jani, R. J. Russo, R. A. Schatz, S. Steuterman, E. M. Guarneri, H. Wu, R. Mehran, G. S. Mintz, M. B. Leon, and P. S. Teirstein, “Quantitative angiographic analysis of stent restenosis in the Scripps Coronary Radiation to Inhibit Intimal Proliferation Post Stenting (SCRIPPS) Trial,” Am. J. Cardiol. 84, 410–414 (1999).
33.M. Höher, J. Wöhrle, M. Wohlfrom, H. Hanke, R. Voisard, H. H. Osterhues, M. Kochs, S. N. Reske, V. Hombach, and J. Kotzerke, “Intracoronary β-irradiation with a liquid -filled balloon, six month results from a clinical safety and feasibility study,” Circulation 101, 2355–2360 (2000).
34.T. Fox, C. Soares, S. B. King III, K. Robinson, L. Davis, and I. Crocker, “Co-linear alignment of a beta-emitting radiation source train: Dose effect of misalignment at the junction,” Advances in Cardiovascular Radiation Therapy II, Washington DC, 8–10 March 1998 (abstract).
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Article metrics loading...